In recent years, there have been major developments in the understanding of
the cell cycle. It is now known that normal cellular proliferation is tigh
tly regulated by the activation and deactivation of a series of proteins th
at constitute the cell cycle machinery. The expression and activity of comp
onents of the cell cycle can be altered during the development of a variety
of diseases where aberrant proliferation contributes to the pathology of t
he illness. Apart from yielding a new source of untapped therapeutic target
s, it is likely that manipulating the activity of such proteins in diseased
states will provide an important route for treating proliferative disorder
s, and the opportunity to develop a novel class of future medicines.